source · text/csv
source_0787b39748d34b87
sha256 2fbfde0f89ad96b42ae873a716dbc2572076ceaa65a2e91dfa9c8ecd377428bd
by researka:v2 · 2026-06-14 01:32:19.971315+04:00
study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness The Mechanistic Target of Rapamycin (mTOR) Pathway as a Target of Anti-aging Therapies: The Role of Rapamycin and Its Analogs in the Regulation of Cellular Processes and Their Impact on Longevity.,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary "Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Rapamycin fed late in life extends lifespan in genetically heterogeneous mice,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
metadata
{
"researka_object_type": "publication_sidecar",
"researka_publication_id": "62637e62-c4f7-4093-85a4-d608a73edbf5",
"researka_submission_id": "27f60a7b-7f92-424c-bb44-65d749454a16",
"sidecar_name": "evidence_table.csv",
"sidecar_url": "https://api.researka.org/publications/62637e62-c4f7-4093-85a4-d608a73edbf5/sidecars/evidence_table.csv"
}